Surveillance of Adverse Events Following Immunization (AEFI) after Third Dose Booster Vaccination with mRNA-Based Vaccine in Universitas Indonesia Hospital Health Personnel

Facing the rising cases of with higher fatalities COVID-19, some countries decided to give the third dose of vaccine as a booster. As of 9 January 2022, 90.31% of health workers in Indonesia have received the third dose vaccine. This study aims to provide an evaluation of adverse events following im...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidayat, Rakhmad, Mustika, Alyssa Putri, Avisha, Fhathia, Djuliannisaa, Zlatikha, Winari, Dinisa Diah, Putri, Ria Amiliah, Lisman, Heydi Marizky, Davin, Vandra, Widhani, Alvina, Aini, Muhammad Hafiz, Rahmadani, Meilisa, Istanti, Novita Dwi, Giantini, Astuti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229967/
https://www.ncbi.nlm.nih.gov/pubmed/35746485
http://dx.doi.org/10.3390/vaccines10060877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229967/
https://www.ncbi.nlm.nih.gov/pubmed/35746485
http://dx.doi.org/10.3390/vaccines10060877

Ejemplares similares